PRODUCT EXPIRY DATE: FEB 2018
Arimidex is a front-line treatment for postmenopausal breast cancer in women, slowing its growth in advanced stages and treating the spread of the disease to other parts of the body.
Arimidex is also able to increase testosterone levels in men, by reducing excess estrogen in the body.
Arimidex breast cancer treatment combats the kind of breast cancer that thrives on estrogen. It is an adjuvant therapy, in other words it is used in addition to primary treatment to reduce the risk of postmenopausal breast cancer returning.
It can be prescribed along with other drugs to treat the early stages of breast cancer in postmenopausal women. As an adjuvant therapy, it is in the same company as chemotherapy drugs, radiation and targeted therapy.
The whole purpose of adjuvant therapies is to help destroy cancer cells that were not removed during surgery and, by so doing, reduce the chances of the disease returning.
Arimidex is used to lower estrogen levels and is particularly helpful in treating breast cancer in postmenopausal women, either in the early stages of the disease or after it has spread to other parts of the body.